Treatment failure in osteoporosis
- PMID: 22836278
- DOI: 10.1007/s00198-012-2093-8
Treatment failure in osteoporosis
Abstract
Guidelines concerning the definition of failure of therapies used to reduce the risk of fracture are provided.
Introduction: This study aims to provide guidelines concerning the definition of failure of therapies used to reduce the risk of fracture.
Methods: A working group of the Committee of Scientific Advisors of the International Osteoporosis Foundation was convened to define outcome variables that may assist clinicians in decision making.
Results: In the face of limited evidence, failure of treatment may be inferred when two or more incident fractures have occurred during treatment, when serial measurements of bone remodelling markers are not suppressed by anti-resorptive therapy and where bone mineral density continues to decrease.
Conclusion: The provision of pragmatic criteria to define failure to respond to treatment provides an unmet clinical need and may stimulate research into an important issue.
Comment in
-
Treatment failure in osteoporosis.Climacteric. 2012 Dec;15(6):632-3. doi: 10.3109/13697137.2012.733634. Climacteric. 2012. PMID: 23174020 No abstract available.
Similar articles
-
One year in review 2018: progress in osteoporosis treatment.Clin Exp Rheumatol. 2018 Nov-Dec;36(6):948-958. Epub 2018 Dec 6. Clin Exp Rheumatol. 2018. PMID: 30526765 Review.
-
Goal-directed treatment of osteoporosis in Europe.Osteoporos Int. 2014 Nov;25(11):2533-43. doi: 10.1007/s00198-014-2787-1. Epub 2014 Sep 9. Osteoporos Int. 2014. PMID: 25199574
-
Review of the guideline of the American College of Physicians on the treatment of osteoporosis.Osteoporos Int. 2018 Jul;29(7):1505-1510. doi: 10.1007/s00198-018-4504-y. Epub 2018 Jun 4. Osteoporos Int. 2018. PMID: 29869039 Free PMC article. Review.
-
Management of glucocorticoid-induced osteoporosis: What is new?Int J Rheum Dis. 2019 Sep;22(9):1595-1597. doi: 10.1111/1756-185X.13680. Int J Rheum Dis. 2019. PMID: 31478605 No abstract available.
-
Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).Osteoporos Int. 2015 Feb;26(2):765-74. doi: 10.1007/s00198-014-2964-2. Epub 2014 Nov 18. Osteoporos Int. 2015. PMID: 25403903 Clinical Trial.
Cited by
-
Heterogeneous osteoimmune profiles via single-cell transcriptomics in osteoporotic patients who fail bisphosphonate treatment.Proc Natl Acad Sci U S A. 2024 Feb 20;121(8):e2316871121. doi: 10.1073/pnas.2316871121. Epub 2024 Feb 12. Proc Natl Acad Sci U S A. 2024. PMID: 38346184 Free PMC article.
-
A diagnostic predictive model for secondary osteoporosis in patients with fragility fracture: a retrospective cohort study in a tertiary care hospital.Arch Osteoporos. 2023 Sep 6;18(1):114. doi: 10.1007/s11657-023-01321-y. Arch Osteoporos. 2023. PMID: 37672126
-
A summary of the Malaysian Clinical Practice Guidelines on the management of postmenopausal osteoporosis, 2022.Osteoporos Sarcopenia. 2023 Jun;9(2):60-69. doi: 10.1016/j.afos.2023.06.002. Epub 2023 Jun 20. Osteoporos Sarcopenia. 2023. PMID: 37496985 Free PMC article. Review.
-
Long-term and sequential treatment for osteoporosis.Nat Rev Endocrinol. 2023 Sep;19(9):520-533. doi: 10.1038/s41574-023-00866-9. Epub 2023 Jul 18. Nat Rev Endocrinol. 2023. PMID: 37464088 Review.
-
Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures.J Clin Med. 2023 Jun 2;12(11):3820. doi: 10.3390/jcm12113820. J Clin Med. 2023. PMID: 37298015 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
